Here we have addressed this issue in the thyroid cancer cell lines WRO and FTC133, which differ in the expression of PTEN and p53, two oncosuppressor proteins that are known to play important roles in glucose metabolism. This evidence concerns the gene PTEN and thyroid gland carcinoma.